Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2015 - OWC Pharmaceutical Research Corp. | owcp12312015.htm |
| EX-31 - EXHIBIT 31.2 - OWC Pharmaceutical Research Corp. | exh31_2.htm |
| EX-32 - EXHIBIT 32.2 - OWC Pharmaceutical Research Corp. | exh32_2.htm |
| EX-31 - EXHIBIT 31.1 - OWC Pharmaceutical Research Corp. | exh31_1.htm |
Exhibit 32.1
CERTIFICATION
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the annual report of OWC Pharmaceutical Research Corp. (the "Company") on Form 10-K for the year ended December 31, 2015 (the "Report"), as filed with the Securities and Exchange Commission on the date hereof, I, Mordechi Bignitz, CEO of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. The
Report fully complies with the requirements of section 13(a) or 15(d) of the Securities
Exchange Act of 1934, as amended; and
2. The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
/s/ Mordechi Bignitz
Mordechi Bignitz
CEO
Dated: April 14, 2016
A signed original of this written statement required by Section 906 has been provided to OWC Pharmaceutical Research Corp. and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.